Report Detail

Request for Sample of this report

Other Global Decentralized Clinical Trials (DCTs) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4528977
    • |
  • 13 April, 2023
    • |
  • Global
    • |
  • 100 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

The FDA defines decentralized clinical trials as those executed through telemedicine and mobile or local healthcare providers, using processes and technologies that differ from the traditional clinical trial model.
Decentralized clinical trials are conducted remotely, with patient subjects remaining at home during a significant portion, or all, of the study. However, the decentralized clinical trial model is designed for more just patient participants.
According to our (Global Info Research) latest study, the global Decentralized Clinical Trials (DCTs) market size was valued at USD 7341.6 million in 2022 and is forecast to a readjusted size of USD 18560 million by 2029 with a CAGR of 14.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Decentralized Clinical Trials (DCTs) key players include Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, etc. Global top five manufacturers hold a share over 45%.
North America is the largest production region, with a share about 60%, followed by Europe and Asia-Pacific, both have a share over 30 percent. In terms of product, Interventional is the largest segment, with a share over 45%. And in terms of application, the largest application is Oncology, followed by Cardiovascular, etc.
This report is a detailed and comprehensive analysis for global Decentralized Clinical Trials (DCTs) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Decentralized Clinical Trials (DCTs) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Decentralized Clinical Trials (DCTs) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Decentralized Clinical Trials (DCTs) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Decentralized Clinical Trials (DCTs) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Decentralized Clinical Trials (DCTs)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Decentralized Clinical Trials (DCTs) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medidata, IQVIA, Labcorp, PRA Health Sciences and Parexel, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Decentralized Clinical Trials (DCTs) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Interventional
Observational
Expanded Access
Market segment by Application
Oncology
Cardiovascular
Others
Market segment by players, this report covers
Medidata
IQVIA
Labcorp
PRA Health Sciences
Parexel
ICON
Oracle
CRF Health
Clinical Ink
Medable
Science 37
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Decentralized Clinical Trials (DCTs) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Decentralized Clinical Trials (DCTs), with revenue, gross margin and global market share of Decentralized Clinical Trials (DCTs) from 2018 to 2023.
Chapter 3, the Decentralized Clinical Trials (DCTs) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Decentralized Clinical Trials (DCTs) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Decentralized Clinical Trials (DCTs).
Chapter 13, to describe Decentralized Clinical Trials (DCTs) research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Decentralized Clinical Trials (DCTs)
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Decentralized Clinical Trials (DCTs) by Type
    • 1.3.1 Overview: Global Decentralized Clinical Trials (DCTs) Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Decentralized Clinical Trials (DCTs) Consumption Value Market Share by Type in 2022
    • 1.3.3 Interventional
    • 1.3.4 Observational
    • 1.3.5 Expanded Access
  • 1.4 Global Decentralized Clinical Trials (DCTs) Market by Application
    • 1.4.1 Overview: Global Decentralized Clinical Trials (DCTs) Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Oncology
    • 1.4.3 Cardiovascular
    • 1.4.4 Others
  • 1.5 Global Decentralized Clinical Trials (DCTs) Market Size & Forecast
  • 1.6 Global Decentralized Clinical Trials (DCTs) Market Size and Forecast by Region
    • 1.6.1 Global Decentralized Clinical Trials (DCTs) Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Decentralized Clinical Trials (DCTs) Market Size by Region, (2018-2029)
    • 1.6.3 North America Decentralized Clinical Trials (DCTs) Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Decentralized Clinical Trials (DCTs) Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size and Prospect (2018-2029)
    • 1.6.6 South America Decentralized Clinical Trials (DCTs) Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Decentralized Clinical Trials (DCTs) Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Medidata
    • 2.1.1 Medidata Details
    • 2.1.2 Medidata Major Business
    • 2.1.3 Medidata Decentralized Clinical Trials (DCTs) Product and Solutions
    • 2.1.4 Medidata Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Medidata Recent Developments and Future Plans
  • 2.2 IQVIA
    • 2.2.1 IQVIA Details
    • 2.2.2 IQVIA Major Business
    • 2.2.3 IQVIA Decentralized Clinical Trials (DCTs) Product and Solutions
    • 2.2.4 IQVIA Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 IQVIA Recent Developments and Future Plans
  • 2.3 Labcorp
    • 2.3.1 Labcorp Details
    • 2.3.2 Labcorp Major Business
    • 2.3.3 Labcorp Decentralized Clinical Trials (DCTs) Product and Solutions
    • 2.3.4 Labcorp Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Labcorp Recent Developments and Future Plans
  • 2.4 PRA Health Sciences
    • 2.4.1 PRA Health Sciences Details
    • 2.4.2 PRA Health Sciences Major Business
    • 2.4.3 PRA Health Sciences Decentralized Clinical Trials (DCTs) Product and Solutions
    • 2.4.4 PRA Health Sciences Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 PRA Health Sciences Recent Developments and Future Plans
  • 2.5 Parexel
    • 2.5.1 Parexel Details
    • 2.5.2 Parexel Major Business
    • 2.5.3 Parexel Decentralized Clinical Trials (DCTs) Product and Solutions
    • 2.5.4 Parexel Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Parexel Recent Developments and Future Plans
  • 2.6 ICON
    • 2.6.1 ICON Details
    • 2.6.2 ICON Major Business
    • 2.6.3 ICON Decentralized Clinical Trials (DCTs) Product and Solutions
    • 2.6.4 ICON Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 ICON Recent Developments and Future Plans
  • 2.7 Oracle
    • 2.7.1 Oracle Details
    • 2.7.2 Oracle Major Business
    • 2.7.3 Oracle Decentralized Clinical Trials (DCTs) Product and Solutions
    • 2.7.4 Oracle Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Oracle Recent Developments and Future Plans
  • 2.8 CRF Health
    • 2.8.1 CRF Health Details
    • 2.8.2 CRF Health Major Business
    • 2.8.3 CRF Health Decentralized Clinical Trials (DCTs) Product and Solutions
    • 2.8.4 CRF Health Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 CRF Health Recent Developments and Future Plans
  • 2.9 Clinical Ink
    • 2.9.1 Clinical Ink Details
    • 2.9.2 Clinical Ink Major Business
    • 2.9.3 Clinical Ink Decentralized Clinical Trials (DCTs) Product and Solutions
    • 2.9.4 Clinical Ink Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Clinical Ink Recent Developments and Future Plans
  • 2.10 Medable
    • 2.10.1 Medable Details
    • 2.10.2 Medable Major Business
    • 2.10.3 Medable Decentralized Clinical Trials (DCTs) Product and Solutions
    • 2.10.4 Medable Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Medable Recent Developments and Future Plans
  • 2.11 Science 37
    • 2.11.1 Science 37 Details
    • 2.11.2 Science 37 Major Business
    • 2.11.3 Science 37 Decentralized Clinical Trials (DCTs) Product and Solutions
    • 2.11.4 Science 37 Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Science 37 Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Decentralized Clinical Trials (DCTs) Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Decentralized Clinical Trials (DCTs) by Company Revenue
    • 3.2.2 Top 3 Decentralized Clinical Trials (DCTs) Players Market Share in 2022
    • 3.2.3 Top 6 Decentralized Clinical Trials (DCTs) Players Market Share in 2022
  • 3.3 Decentralized Clinical Trials (DCTs) Market: Overall Company Footprint Analysis
    • 3.3.1 Decentralized Clinical Trials (DCTs) Market: Region Footprint
    • 3.3.2 Decentralized Clinical Trials (DCTs) Market: Company Product Type Footprint
    • 3.3.3 Decentralized Clinical Trials (DCTs) Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Decentralized Clinical Trials (DCTs) Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Decentralized Clinical Trials (DCTs) Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Decentralized Clinical Trials (DCTs) Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Decentralized Clinical Trials (DCTs) Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Decentralized Clinical Trials (DCTs) Consumption Value by Type (2018-2029)
  • 6.2 North America Decentralized Clinical Trials (DCTs) Consumption Value by Application (2018-2029)
  • 6.3 North America Decentralized Clinical Trials (DCTs) Market Size by Country
    • 6.3.1 North America Decentralized Clinical Trials (DCTs) Consumption Value by Country (2018-2029)
    • 6.3.2 United States Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Decentralized Clinical Trials (DCTs) Consumption Value by Type (2018-2029)
  • 7.2 Europe Decentralized Clinical Trials (DCTs) Consumption Value by Application (2018-2029)
  • 7.3 Europe Decentralized Clinical Trials (DCTs) Market Size by Country
    • 7.3.1 Europe Decentralized Clinical Trials (DCTs) Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)
    • 7.3.3 France Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region
    • 8.3.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Consumption Value by Region (2018-2029)
    • 8.3.2 China Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)
    • 8.3.5 India Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Decentralized Clinical Trials (DCTs) Consumption Value by Type (2018-2029)
  • 9.2 South America Decentralized Clinical Trials (DCTs) Consumption Value by Application (2018-2029)
  • 9.3 South America Decentralized Clinical Trials (DCTs) Market Size by Country
    • 9.3.1 South America Decentralized Clinical Trials (DCTs) Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country
    • 10.3.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Decentralized Clinical Trials (DCTs) Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Decentralized Clinical Trials (DCTs) Market Drivers
  • 11.2 Decentralized Clinical Trials (DCTs) Market Restraints
  • 11.3 Decentralized Clinical Trials (DCTs) Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Decentralized Clinical Trials (DCTs) Industry Chain
  • 12.2 Decentralized Clinical Trials (DCTs) Upstream Analysis
  • 12.3 Decentralized Clinical Trials (DCTs) Midstream Analysis
  • 12.4 Decentralized Clinical Trials (DCTs) Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Decentralized Clinical Trials (DCTs). Industry analysis & Market Report on Decentralized Clinical Trials (DCTs) is a syndicated market report, published as Global Decentralized Clinical Trials (DCTs) Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Decentralized Clinical Trials (DCTs) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,225.96
    		4,838.94
    		6,451.92
    		542,984.40
    		814,476.60
    		1,085,968.80
    		290,649.60
    		435,974.40
    		581,299.20
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo